The urine-based molecular test can quickly and accurately detect bladder cancer and streamline diagnosis, reducing the need for invasive cystoscopies.
International analysis has found that discordant results between two types of HPV test linked with worse outcomes for patients
New study uncovers the information encoded in our DNA required for the transcriptional control of blood cell development from embryonic stem cells
New and innovative ways to detect and treat cancer being trialled at Birmingham are to receive renewed funding from Cancer Research UK and the NIHR.
Across 2022, Professor Jo Morris, from the Institute of Cancer and Genomics, has secured more than £4.9 million to better understand DNA replication and repair.
Two University of Birmingham researchers have been awarded prestigious Medical Research Council (MRC) clinical fellowships this year.
Children and adult with a rare form of bone cancer are receiving a new standard of treatment that is more effective, thanks to a CRCTU clinical trial.
Some leukemias evade treatment by changing their appearance and identity through changing the read-out of their DNA, a new study has found.
A new trial found that an AI app-based reader for lateral flow devices reduced false Covid negatives in assisted test sites.
Renewed National Institute for Health and Care Research Birmingham Biomedical Research Centre continue funds for developments around inflammatory diseases